News/ News/ Oncology Blueprint gets first approval as FDA backs stomach cancer drug Richard Staines Blueprint, cancer, fda, stomach cancer 0 Comment US biotech Blueprint Medicines has its first approved drug, after the FDA backed its oncology drug Ayvakit for Share X Blueprint gets first approval as FDA backs stomach cancer drug https://pharmaphorum.com/news/blueprint-gets-first-approval-as-fda-backs-stomach-cancer-drug/
News/ News/ Oncology Blueprint eyes quick filing for GIST drug avapritinib Phil Taylor Blueprint, cancer, gastroenterology 0 Comment Blueprint Medicines has new data for its lead cancer drug avapritinib in gastrointestinal stromal tumours (GIST) that set Share X Blueprint eyes quick filing for GIST drug avapritinib https://pharmaphorum.com/news/blueprint-eyes-quick-filing-for-gist-drug-avapritinib/
